Company profile
Perspectum
Perspectum has 1 AI-enabled medical device on the FDA list. The first decision was on September 6, 2022 and the most recent on September 6, 2022 (LiverMultiScan v5 (LMSv5)). Its most common review panel is Radiology (1 device).
1AI devices
2022First decision
2022Latest decision
1Specialties
Timeline
- LiverMultiScan v5 (LMSv5) · Radiology · LNH